A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up
Top Cited Papers
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 108 (6) , 929-937
- https://doi.org/10.1067/mai.2001.120015
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prevention of acute urticaria in young children with atopic dermatitisJournal of Allergy and Clinical Immunology, 2001
- A Clinical Index to Define Risk of Asthma in Young Children with Recurrent WheezingAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitisJournal of Allergy and Clinical Immunology, 1999
- Atopic dermatitis in early infancy predicts allergic airway disease at 5 yearsClinical and Experimental Allergy, 1998
- Allergic factors associated with the development of asthma and the influence of cetirizine in a double‐blind, randomised, placebo‐controlled trial: First results of ETA®Pediatric Allergy and Immunology, 1998
- The development of allergy in high‐risk childrenClinical and Experimental Allergy, 1997
- Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplinesPediatric Allergy and Immunology, 1997
- Childhood asthma and lung function in mid-adult lifePediatric Pulmonology, 1997
- Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthmaJournal of Allergy and Clinical Immunology, 1992
- Prognosis of Asthma from Childhood to AdulthoodAmerican Review of Respiratory Disease, 1989